Literature DB >> 15322006

Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation.

Teresa A Urban1, Adam Griffith, Anastasia M Torok, Mark E Smolkin, Jane L Burns, Joanna B Goldberg.   

Abstract

Burkholderia cenocepacia is an opportunistic pathogen that can cause severe lung infections in cystic fibrosis patients. To understand the contribution of B. cenocepacia flagella to infection, a strain mutated in the major flagellin subunit, fliCII, was constructed in B. cenocepacia K56-2 and tested in a murine agar bead model of lung infection. C57/BL6 mice infected with approximately 10(8) wild-type K56-2 bacteria exhibited 40% mortality after 3 days, whereas no mortality was noted in mice infected with the fliCII mutant. Among the mice surviving the infection with either strain, there was no significant difference in the bacterial loads in the lungs and spleen, bacteremia, weight loss, or infiltration of immune effector cells at 3 days postinfection. Similar results were observed at 24 h, prior to expression of the lethality phenotype. KC, a murine interleukin-8 (IL-8) homolog, was elevated in both the bronchoalveolar lavage fluid and serum of mice infected with the wild type compared to the fliCII mutant at 24 h, suggesting that flagella stimulated host cells. To demonstrate that flagella contributed to these responses, the interaction between B. cenocepacia and Toll-like receptor 5 (TLR5) was investigated. Infection of HEK293 cells with heat-killed wild-type K56-2, but not infection with the fliCII mutant, resulted in both NF-kappaB activation and IL-8 secretion that was dependent upon expression of TLR5. Together, these results demonstrate that B. cenocepacia flagella contribute to virulence in an in vivo infection model, and that induction of host immune responses through interaction with TLR5 may contribute to its overall pathogenic potential.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322006      PMCID: PMC517433          DOI: 10.1128/IAI.72.9.5126-5134.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Role of Toll-like receptors in pathogen recognition.

Authors:  S Janssens; R Beyaert
Journal:  Clin Microbiol Rev       Date:  2003-10       Impact factor: 26.132

2.  Mining genomes: correlating tandem mass spectra of modified and unmodified peptides to sequences in nucleotide databases.

Authors:  J R Yates; J K Eng; A L McCormack
Journal:  Anal Chem       Date:  1995-09-15       Impact factor: 6.986

3.  Immunoaffinity purification of tyrosine-phosphorylated cellular proteins.

Authors:  S B Kanner; A B Reynolds; J T Parsons
Journal:  J Immunol Methods       Date:  1989-06-02       Impact factor: 2.303

4.  Allelic exchange in Pseudomonas aeruginosa using novel ColE1-type vectors and a family of cassettes containing a portable oriT and the counter-selectable Bacillus subtilis sacB marker.

Authors:  H P Schweizer
Journal:  Mol Microbiol       Date:  1992-05       Impact factor: 3.501

5.  Pseudomonas cepacia infection in cystic fibrosis: an emerging problem.

Authors:  A Isles; I Maclusky; M Corey; R Gold; C Prober; P Fleming; H Levison
Journal:  J Pediatr       Date:  1984-02       Impact factor: 4.406

6.  Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis.

Authors:  E Mahenthiralingam; M E Campbell; D P Speert
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

7.  Interleukin-8: an important chemoattractant in sputum of patients with chronic inflammatory airway diseases.

Authors:  J B Richman-Eisenstat; P G Jorens; C A Hébert; I Ueki; J A Nadel
Journal:  Am J Physiol       Date:  1993-04

8.  Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist.

Authors:  M J Thomassen; C A Demko; J D Klinger; R C Stern
Journal:  Am Rev Respir Dis       Date:  1985-05

9.  Flagella, motility and invasive virulence of Pseudomonas aeruginosa.

Authors:  D Drake; T C Montie
Journal:  J Gen Microbiol       Date:  1988-01

10.  Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition.

Authors:  M A Luzar; M J Thomassen; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

View more
  38 in total

Review 1.  A decade of Burkholderia cenocepacia virulence determinant research.

Authors:  Slade A Loutet; Miguel A Valvano
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

2.  Class 2 integron with a novel cassette array in a Burkholderia cenocepacia isolate.

Authors:  María Soledad Ramírez; Liliana Jordá Vargas; Viviana Cagnoni; Marta Tokumoto; Daniela Centrón
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract.

Authors:  M Chelsea Lane; Virginia Lockatell; Greta Monterosso; Daniel Lamphier; Julia Weinert; J Richard Hebel; David E Johnson; Harry L T Mobley
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

4.  Targeting pan-resistant bacteria with antibodies to a broadly conserved surface polysaccharide expressed during infection.

Authors:  David Skurnik; Michael R Davis; Dennis Benedetti; Katie L Moravec; Colette Cywes-Bentley; Damien Roux; David C Traficante; Rebecca L Walsh; Tomas Maira-Litràn; Sara K Cassidy; Christina R Hermos; Thomas R Martin; Erin L Thakkallapalli; Sara O Vargas; Alexander J McAdam; Tami D Lieberman; Roy Kishony; John J Lipuma; Gerald B Pier; Joanna B Goldberg; Gregory P Priebe
Journal:  J Infect Dis       Date:  2012-03-23       Impact factor: 5.226

5.  Identification of the flagellin glycosylation system in Burkholderia cenocepacia and the contribution of glycosylated flagellin to evasion of human innate immune responses.

Authors:  Anna Hanuszkiewicz; Paula Pittock; Fiachra Humphries; Hermann Moll; Amanda Roa Rosales; Antonio Molinaro; Paul N Moynagh; Gilles A Lajoie; Miguel A Valvano
Journal:  J Biol Chem       Date:  2014-05-19       Impact factor: 5.157

6.  Immune Recognition of the Epidemic Cystic Fibrosis Pathogen Burkholderia dolosa.

Authors:  Damien Roux; Molly Weatherholt; Bradley Clark; Mihaela Gadjeva; Diane Renaud; David Scott; David Skurnik; Gregory P Priebe; Gerald Pier; Craig Gerard; Deborah R Yoder-Himes
Journal:  Infect Immun       Date:  2017-05-23       Impact factor: 3.441

7.  Identification of Poly-N-acetylglucosamine as a Major Polysaccharide Component of the Bacillus subtilis Biofilm Matrix.

Authors:  Damien Roux; Colette Cywes-Bentley; Yi-Fan Zhang; Stephanie Pons; Melissa Konkol; Daniel B Kearns; Dustin J Little; P Lynne Howell; David Skurnik; Gerald B Pier
Journal:  J Biol Chem       Date:  2015-06-15       Impact factor: 5.157

8.  Burkholderia xenovorans LB400 harbors a multi-replicon, 9.73-Mbp genome shaped for versatility.

Authors:  Patrick S G Chain; Vincent J Denef; Konstantinos T Konstantinidis; Lisa M Vergez; Loreine Agulló; Valeria Latorre Reyes; Loren Hauser; Macarena Córdova; Luis Gómez; Myriam González; Miriam Land; Victoria Lao; Frank Larimer; John J LiPuma; Eshwar Mahenthiralingam; Stephanie A Malfatti; Christopher J Marx; J Jacob Parnell; Alban Ramette; Paul Richardson; Michael Seeger; Daryl Smith; Theodore Spilker; Woo Jun Sul; Tamara V Tsoi; Luke E Ulrich; Igor B Zhulin; James M Tiedje
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

9.  Transcriptional response of Burkholderia cenocepacia J2315 sessile cells to treatments with high doses of hydrogen peroxide and sodium hypochlorite.

Authors:  Elke Peeters; Andrea Sass; Eshwar Mahenthiralingam; Hans Nelis; Tom Coenye
Journal:  BMC Genomics       Date:  2010-02-05       Impact factor: 3.969

10.  Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection.

Authors:  Ana S Moreira; Dalila Mil-Homens; Sílvia A Sousa; Carla P Coutinho; Ana Pinto-de-Oliveira; Christian G Ramos; Sandra C Dos Santos; Arsénio M Fialho; Jorge H Leitão; Isabel Sá-Correia
Journal:  Virulence       Date:  2016-09-21       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.